324 related articles for article (PubMed ID: 12879419)
1. Osteoclast diseases.
Helfrich MH
Microsc Res Tech; 2003 Aug; 61(6):514-32. PubMed ID: 12879419
[TBL] [Abstract][Full Text] [Related]
2. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
3. Genetic regulation of osteoclast development and function.
Teitelbaum SL; Ross FP
Nat Rev Genet; 2003 Aug; 4(8):638-49. PubMed ID: 12897775
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast diseases and dental abnormalities.
Helfrich MH
Arch Oral Biol; 2005 Feb; 50(2):115-22. PubMed ID: 15721137
[TBL] [Abstract][Full Text] [Related]
5. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
6. New knowledge on the origin, function and fate of osteoclasts.
Bonucci E
Clin Orthop Relat Res; 1981; (158):252-69. PubMed ID: 6268344
[TBL] [Abstract][Full Text] [Related]
7. Osteopetrosis--multiple pathways for the interception of osteoclast function.
Marks SC
Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
[TBL] [Abstract][Full Text] [Related]
9. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
11. Update on the pathogenesis of osteolysis in multiple myeloma patients.
Giuliani N; Colla S; Rizzoli V
Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
[TBL] [Abstract][Full Text] [Related]
12. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge.
Kim HH; Kim JH; Kwak HB; Huang H; Han SH; Ha H; Lee SW; Woo ER; Lee ZH
Biochem Pharmacol; 2004 May; 67(9):1647-56. PubMed ID: 15081864
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
15. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
Theoleyre S; Wittrant Y; Tat SK; Fortun Y; Redini F; Heymann D
Cytokine Growth Factor Rev; 2004 Dec; 15(6):457-75. PubMed ID: 15561602
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
17. [Structure and ultrastructure of osteoblasts and of the osteoid tissue in Paget's disease of bone (author's transl)].
Basle M; Minard MF; Rebel A
Pathol Biol (Paris); 1978 Nov; 26(8):475-9. PubMed ID: 370741
[TBL] [Abstract][Full Text] [Related]
18. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening.
Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA
J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469
[TBL] [Abstract][Full Text] [Related]
19. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]